Elon Musk’s rocket venture, SpaceX, has finally filed for its long-awaited initial public offering, and the City is bracing for a storm. The prospectus lands at a precarious moment: inflation stubbornly above the Bank of England’s 2% target, gilt yields climbing, and the FTSE 100 already jittery. As chief financial editor, I see three critical factors for UK investors to digest before committing capital.
First, valuation is a problem. SpaceX is reportedly seeking a market capitalisation well north of $150 billion. That makes it one of the most valuable companies on Earth, despite revenues that are modest by tech standards. The company’s Starlink satellite internet business is growing, but it remains loss-making. The core launch business, while dominant, faces increasing competition from rivals like Rocket Lab and Blue Origin. UK investors, already burned by over-hyped US tech listings, should ask: where is the margin of safety? At these levels, you are betting on Musk’s vision, not on current cash flows. The market’s recent love affair with unprofitable growth has soured. This could be a classic case of buying the hype.
Second, volatility will be extreme. SpaceX shares will be a rollercoaster on both sides of the Atlantic. The company’s fortunes are tied to Musk’s every tweet, regulatory approvals for Starship, and NASA contracts. For UK retail investors, who often pile into US IPOs via spread betting or CFDs, the risk of a 20% intraday swing is real. Institutional investors will hedge furiously, using options and futures, but the retail crowd could get crushed. I recall the disaster of the Rivian IPO, which crashed 80% from its peak. SpaceX is not Rivian, but the pattern is similar: enormous hype, questionable profits, and a founder with a cult following. The lesson? Do not chase the first-day pop. Let the dust settle.
Third, there is the currency and tax angle. The IPO will be in US dollars, so sterling weakness is an extra headwind. If the pound drops further against the dollar, your returns in GBP could be eroded. Moreover, UK capital gains tax and stamp duty add friction. For high-net-worth investors, it may be better to buy via a US broker or an ISA wrapper if possible. The Labour government is rumoured to be eyeing tighter rules on offshore holdings, so compliance is key. For funds, the question is whether to overweight US space stocks at the expense of UK aerospace giants like BAE Systems or Rolls-Royce. My advice: if you must buy, allocate no more than 2% of your portfolio. Treat it as a venture bet, not a core holding.
The broader market impact should not be ignored. A successful SpaceX IPO would suck liquidity from other sectors, as fund managers rebalance. We have seen this before with the Arm Holdings float, which hoovered up capital and then traded sideways. With bond yields offering real returns for the first time in years, the opportunity cost of chasing high-risk tech is rising. Prudent investors should wait for the lock-up period to expire and see how insiders behave. If they sell, you should too.
Bottom line: The SpaceX IPO is a spectacle, but not a guaranteed money-maker. UK investors should approach with caution, a long-term horizon, and a tolerance for turbulence. In this market, patience is a virtue, not a vice.
